← Open Payments lookup

KIMBERLY MCHUGH: Open Payments

NPI 1750770772 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,082 in 53 payments from 14 companies in 2025. Trend: 2023 $826 · 2024 $799 · 2025 $1,082

Food & beverage: $983Education: $99
CompanyPaymentsAmount
GlaxoSmithKline, LLC.18$353
Insmed, Inc.10$138
Actelion Pharmaceuticals US, Inc.2$127
Verona Pharma, Inc.4$89
GENZYME CORPORATION4$77
Boehringer Ingelheim Pharmaceuticals, Inc.2$52
Vifor Pharma, Inc.2$48
PFIZER INC.2$45
Regeneron Healthcare Solutions, Inc.2$36
AstraZeneca Pharmaceuticals LP2$34

Products named: TRELEGY ELLIPTA, Arikayce, OPSUMIT, DUPIXENT, NUCALA, Ohtuvayre, OFEV, Zemaira.

Industry payments across TX — which companies pay providers there.